Novartis to acquire US-based Mariana Oncology in $1.75 bn deal

03 May 2024

Swiss drug maker Novartis has agreed to acquire US-based Mariana Oncology in a deal worth $1.75 billion, as the company seeks advance the development of precision treatment for cancer.

Novartis announces strategic review of its India business

19 Feb 2024

Swiss pharma multinational Novartis AG has started a strategic review of its Indian arm, possibly with the intent of selling it off.

Novartis to cut up to 8,000 jobs globally as it restructures business

01 Jul 2022

Novartis to acquire US cancer drugs maker Endocyte for $2.1 billion

19 Oct 2018

Novartis to pay up to $1 bn for experimental skin drug

20 Jul 2018

Novartis plans to spin off eye care division Alcon; buy back, $5 bn shares

29 Jun 2018

Aurobindo in race to acquire generic dermatology business from Novartis

07 May 2018

GSK to sell Horlicks and India business for $4 bn to acquire Novartis

28 Mar 2018

Novartis buys out cancer specialist AAA in $3.9 bn deal

01 Nov 2017

The move would give Novartis a platform in radiopharmaceuticals and access to a new therapy for the kind of cancer that killed Apple founder Steve Jobs

Novartis begins human testing of new anti-malaria drug

21 Aug 2017

Sun Pharma acquires Novartis' oncology brand Odomzo

22 Dec 2016

Novartis to buy privately-held British biotech company Ziarco Group

16 Dec 2016

Google and Novartis put off scheduled test of smart contact lens

22 Nov 2016

Novartis to buy Selexys Pharmaceuticals for up to $665 mn

21 Nov 2016

Novartis to take on Pfizer’s Ibrance with Ribociclib for breast cancer

10 Oct 2016

US FDA approves Novartis’s biosimilar copy of Amgen’s Enbrel

01 Sep 2016

Novartis' S Korea executives charged with bribing doctors

13 Aug 2016

FDA rejects Novartis’ application for Amgen’s Neulasta biosimilar

20 Jul 2016

Novartis to split pharmaceuticals division into two business units

18 May 2016

Swiss drugmaker Novartis AG yesterday said that it is splitting its pharmaceuticals division into two business units, Novartis Pharmaceuticals and Novartis Oncology

Novartis under criminal investigation in S Korea for offering kickbacks to doctors

25 Apr 2016

Novartis to sell stake in Roche worth $13.8 bn

25 Apr 2016

Sun Pharma in talks to buy Novartis’ Japan portfolio

14 Nov 2015

GSK to sell its multiple sclerosis treatment drug to Novartis for $1 bn

21 Aug 2015

Novartis to sell new heart failure drug for 80 per cent more than projected

09 Jul 2015

US claims $3.3 bn in Novartis kickback lawsuit

01 Jul 2015

Novartis is accused of referring patients to specialty pharmacies and paying kickbacks in the form of rebates to get them to recommend the drugs to patients to boost sales